JADE-001

N/A

Report date: 2026/05/02 20:00:18

Base Information

Drug NameJADE-001
Drug Alias NameJADE-001JADE001PR030PR-030JADE101 +[6] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionTumor necrosis factor ligand superfamily member 13 inhibitors
TargetsTumor necrosis factor ligand superfamily member 13
Therapy Area/IndicationsGlomerulonephritis, IGA
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew Zealand
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesParagon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesJade Biosciences IncParagon Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGlomerulonephritis, IGA
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A